Sarah Riehl
Psychiatry · Farmington Hills, MINPI 1104053206
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 234 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,106, 2.7 times the $407 reported in 2019.
Across 234 payments — averaging $15.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$694
- Lundbeck LLC$575
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$465
- Corium, LLC$378
- Takeda Pharmaceuticals U.S.A., Inc.$240
- Johnson & Johnson$193
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,552100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 61 | $694 |
| Lundbeck LLC | 33 | $575 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 28 | $465 |
| Corium, LLC | 21 | $378 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $240 |
| Johnson & Johnson | 9 | $193 |
| Ironshore Pharmaceuticals Inc. | 9 | $180 |
| Otsuka America Pharmaceutical, Inc. | 8 | $136 |
| Supernus Pharmaceuticals, Inc. | 7 | $119 |
| Tris Pharma Inc | 6 | $91 |
| Axsome Therapeutics, Inc. | 5 | $88 |
| Vanda Pharmaceuticals Inc. | 4 | $79 |
| Avanir Pharmaceuticals, Inc. | 4 | $76 |
| Alkermes, Inc. | 3 | $73 |
| Collegium Pharmaceutical, Inc. | 4 | $67 |
| OWP Pharmaceuticals, Inc. | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 1 | $24 |
| Adlon Therapeutics L.p. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Sage Therapeutics, LLC | 1 | $16 |
How this compares
$3,564 in reported general payments places this provider in the 85th percentile of 1,166 psychiatry providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 21 | $109 |
| Zolpidem Tartrate | 13 | $52 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Farmington Hills
- Leonard RosenFarmington Hills$11K
- Andreas SidiropoulasDetroit$2.8M
- Welton WashingtonYpsilanti$1.4M
- Joel YoungRochester Hills$1.1M
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Robert LagrouClarkston$267K
- Michael IngramBay City$255K
- Samuel WedesLivonia$158K
- Arash JavanbakhtDetroit$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.